SAPIENCE THERAPEUTICS
Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Our drug development program involves translating science into novel therapies, and our initial goal is to develop a first-in-class treatment for glioblastoma multiforme (GBM), which is the most severe and deadly form of brain cancer. The company was founded in 2015 by Barry Kappel and is based in Scarsdale, New York, United States.
SAPIENCE THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
2015-01-01
Address:
Scarsdale, New York, United States
Country:
United States
Website Url:
http://www.sapiencetherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
914-607-6931
Total Funding:
71.51 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Apache Euro Microsoft Exchange Online
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Eureka Therapeutics
Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Kinaset Therapeutics
Kinaset Therapeutics is a therapeutics company that focuses on advancement of novel drugs in areas of unmet medical needs.
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
Oncoheroes Biosciences
Oncoheroes Biosciences is a biotech company.
Potenza Therapeutics
Potenza Therapeutics is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Tryptamine Therapeutics
Tryp Identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs.
Larimar Therapeutics
Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases.
Current Employees Featured
Founder
Investors List
Kingdon Capital
Kingdon Capital investment in Series B - Sapience Therapeutics
NexPoint
NexPoint investment in Series B - Sapience Therapeutics
Bristol Myers Squibb
Bristol Myers Squibb investment in Series B - Sapience Therapeutics
Eshelman Ventures
Eshelman Ventures investment in Series B - Sapience Therapeutics
NexPoint
NexPoint investment in Convertible Note - Sapience Therapeutics
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases investment in Grant - Sapience Therapeutics
Connectivity Ventures Fund
Connectivity Ventures Fund investment in Venture Round - Sapience Therapeutics
TaiAn Technologies
TaiAn Technologies investment in Series A - Sapience Therapeutics
Healthlink Capital
Healthlink Capital investment in Series A - Sapience Therapeutics
Eshelman Ventures
Eshelman Ventures investment in Series A - Sapience Therapeutics
Official Site Inspections
http://www.sapiencetherapeutics.com Semrush global rank: 4.88 M Semrush visits lastest month: 1.8 K
- Host name: 228.98.139.34.bc.googleusercontent.com
- IP address: 34.139.98.228
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Sapience Therapeutics"
Management Team - Sapience Therapeutics
Dong, MPPM, CMA, SPHR has over 25 years of experience in accounting, strategic planning, budgeting, forecasting, organization development, financial systems and controls. Prior to …See details»
Board of Directors - Sapience Therapeutics
Robert Ruffolo is the retired President of Research and Development for Wyeth Pharmaceuticals, and Corporate Senior Vice President of Wyeth (now Pfizer). In that role, Dr. Ruffolo managed …See details»
Sapience Therapeutics, Inc. | LinkedIn
Sapience Therapeutics, Inc. Biotechnology Research Tarrytown, New York 3,911 followers Changing the Tide to Achieve the UnachievableSee details»
Sapience Therapeutics - Crunchbase Company Profile & Funding
Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers.See details»
Sapience Therapeutics Strengthens Board of Directors and …
Dec 5, 2024 Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune …See details»
Sapience Therapeutics Strengthens Board of Directors …
Dec 5, 2024 -Sapience appoints Pamela Esposito, Ph.D. to its Board and Augustine Bourne as VP, Business Development-. TARRYTOWN, N.Y., Dec. 5, 2024 /PRNewswire/ -- Sapience Therapeutics, Inc., a clinical ...See details»
Orphanet: SAPIENCE THERAPEUTICS INC
Phone 1: [email protected]. More information. Additional information. Activities of this person. Clinical trial(s) (1) Orphan designation(s) and orphan drug(s) (3) The documents …See details»
Sapience Therapeutics - Overview, News & Similar companies
Feb 27, 2023 Sapience Therapeutics contact info: Phone number: (914) 607-6931 Website: www.sapiencetherapeutics.com What does Sapience Therapeutics do? Sapience …See details»
Sapience Therapeutics Company Profile | Management and
Company Name. Sapience Therapeutics. Main Industry. Research & Development, Business Services. Website. www.sapiencetherapeutics.comSee details»
About Us - Sapience Therapeutics
A TEAM PASSIONATE ABOUT BREAKING BOUNDARIES AND DELIVERING NEW POSSIBILITIES. Sapience Therapeutics is a clinical-stage biotechnology company bringing …See details»
Sapience Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.sapiencetherapeutics.com. Last update 08 Mar 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. Tags. …See details»
Sapience Therapeutics - Craft
Sapience Therapeutics is a company that discovers and develops peptide-based therapeutics. Its drug candidates target protein-protein interactions (PPIs) that are responsible for either …See details»
Sapience Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Sapience Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Sapience Therapeutics - workinbiotech.com
Sapience Therapeutics is developing peptide therapeutics to provide new treatment options for cancer patients. Transcription factors are important proteins that control which genes are …See details»
Sapience Therapeutics Receives FDA Orphan Drug Designation for …
Dec 19, 2024 Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune …See details»
About - Sapience Therapeutics
Contact. 520 White Plains Road Second Floor Tarrytown, NY 10591 Tel: (914) 418-5100See details»
Sapience Therapeutics - VentureRadar
Similar Companies: Aileron Therapeutics USA Publicly Traded Aileron Therapeutics is a clinical stage biopharmaceutical company that is developing first-in-class therapeutics based on its …See details»
Sapience Therapeutics Receives FDA Orphan Drug Designation
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for …See details»
Sapience Therapeutics Receives FDA Orphan Drug Designation for …
TARRYTOWN, N.Y., Dec. 19, 2024 /PRNewswire/ -- Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to …See details»